Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Giuseppe Tambussi
Affiliation
ORCID
Career Start Year
1988
Papers
171
H Index
45
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35443987
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy.
Sexually Transmitted Infections
2023
34141442
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium.
J Virus Erad
2021
34127581
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort.
AIDS
2021
32578947
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort.
HIV Med
2020
32258852
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study.
Pathog Immun
2020
32040959
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.
Annals of Internal Medicine
2020
33135083
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
New Microbiologica
2020
31157663
The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.
AIDS
2019
31688043
Rhodococcus defluvii pneumonia: first reported case in humans.
AIDS
2019
29369157
HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy.
AIDS
2018
29451870
Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.
PLoS ONE
2018
29427230
Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.
AIDS Behav
2018
28211903
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control.
Scientific Reports
2017
28333303
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response.
Journal of Antimicrobial Chemotherapy
2017
28887441
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells.
Nature Communications
2017
28533305
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.
Journal of the American Heart Association
2017
29088236
Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males.
PLoS ONE
2017
29206853
Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort.
PLoS ONE
2017
28276994
Immunosenescence and hurdles in the clinical management of older HIV-patients.
Virulence
2017
27798217
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.
Journal of Antimicrobial Chemotherapy
2017
27865174
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up.
Journal of Clinical Virology
2016
26888911
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.
Journal of Antimicrobial Chemotherapy
2016
26908786
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies.
Clinical Infectious Diseases
2016
26985593
HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma.
Journal of Clinical Virology
2016
27070122
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.
Journal of acquired immune deficiency syndromes (1999)
2016
26684819
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial.
AIDS
2016
26571377
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project.
New Microbiol
2015
25711323
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
HIV Med
2015
25870986
The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels.
AIDS
2015
25608585
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.
Journal of Antimicrobial Chemotherapy
2015
26232000
Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy.
Journal of the International AIDS Society
2015
26474181
Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.
PLoS ONE
2015
25980351
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.
Clinical Microbiology and Infection
2015
26449164
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption.
Nature Communications
2015
24961156
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.
Retrovirology
2014
25393989
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection.
Journal of the International AIDS Society
2014
24442223
Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy.
J Acquir Immune Defic Syndr
2014
24300544
Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.
AIDS
2014
24419069
Immunological recovery after 24 weeks of antiretroviral therapy in patients with X4 virus during primary HIV infection.
Journal of acquired immune deficiency syndromes (1999)
2014
25217531
HIV-1 DNA predicts disease progression and post-treatment virological control.
Elife
2014
24858641
Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine.
New Microbiologica
2014
23323897
Short-course antiretroviral therapy in primary HIV infection.
New England Journal of Medicine
2013
24081951
Calcitonin gene-related peptide inhibits Langerhans cell-mediated HIV-1 transmission.
Journal of Experimental Medicine
2013
24205183
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.
PLoS ONE
2013
23945504
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.
AIDS
2013
24075081
Identification and experimental validation of an HIV model for HAART treated patients.
Computer Methods and Programs in Biomedicine
2013
23343911
B-cell subset alterations and correlated factors in HIV-1 infection.
AIDS
2013
21963950
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses.
Journal of Immunological Methods
2012
22550117
Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study.
Clin Infect Dis
2012
22728751
Monotherapy with atazanavir as a simplification strategy: results from an observational study.
Journal of acquired immune deficiency syndromes (1999)
2012
1 - 50 of 171
Column Actions
Search
Recommended Authors
Collaborators
David A Cooper
Co-authored papers
14
Sarah Fidler
Co-authored papers
12
Fabrizio Veglia
Co-authored papers
6
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Co-authored papers
4
Carlo Torti
"Magna Graecia" University
Co-authored papers
4
Hans-Jürgen Stellbrink
Co-authored papers
3
Michael M Lederman
Co-authored papers
3
Mary Carrington
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers
2
Josep M Llibre
Co-authored papers
2
Jason F Okulicz
Co-authored papers
2
Michael J Silverberg
Kaiser Permanente Northern California
Co-authored papers
2
Keith Henry
Co-authored papers
2
Oliver Laeyendecker
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Co-authored papers
2
Frederick M Hecht
Co-authored papers
2
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Co-authored papers
2
Amalio Telenti
Vir Biotechnology Inc.
Co-authored papers
2
Giovanni Guaraldi
University Hospital of Modena Policlinico, University of Modena and Reggio Emilia
Co-authored papers
2
Alicja Trocha
Ragon Institute of MGH
Co-authored papers
1
Gavin X McLeod
Co-authored papers
1
William F Owen
Co-authored papers
1
Wenoah Veikley
Co-authored papers
1
Charles Walworth
Co-authored papers
1
Paul J McLaren
Co-authored papers
1
Hendrik Streeck
Co-authored papers
1
Jay A Levy
Co-authored papers
1
Craig Nielsen
Co-authored papers
1
Edward C Oldfield
Co-authored papers
1
Frank Rhame
Co-authored papers
1
Randy Taplitz
Co-authored papers
1
Clifford G Wlodaver
Co-authored papers
1
1 - 30